60 Degrees Pharmaceuticals, Inc. share price logo

60 Degrees Pharmaceuticals, Inc.

NASDAQ: SXTP

$0.96

-0.05

(-5.32%)

as on

60 Degrees Pharmaceuticals, Inc. Stock Performance

as on November 5, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.92
    $0.99
    downward going graph

    3.80%

    Downside

    3.52%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.59
    $8.62
    downward going graph

    38.51%

    Downside

    801.39%

    Upside

    downward going graph

60 Degrees Pharmaceuticals, Inc. share price movements today

Previous Close
$1.01
Open
$0.96
Volume
188.7K
Market Cap
$3.6M
Day's Low - High
$0.92 - $0.99
52 Week Low - High
$0.59 - $8.62

60 Degrees Pharmaceuticals, Inc. Historical Returns

1 Month Return
-33.59 %
3 Month Return
-21.61 %
1 Year Return
-81.61 %
3 Year Return
-99.4 %
5 Year Return
0 %

60 Degrees Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Check 60 Degrees Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.6M

EPS (TTM)

-6.05

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.17

Industry PE ratio

-3.24

PEG Ratio

-0.00

EBITDA

-8.0M

Revenue (TTM)

1.1M

Profit Margin

19.42%

Return On Equity TTM

-211.59%

60 Degrees Pharmaceuticals, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 60 Degrees Pharmaceuticals, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
60 Degrees Pharmaceuticals, Inc. image
60 Degrees Pharmaceuticals, Inc.
Buy$3.6MNA-0.1719.42%0.00%
Moderna image
Moderna
Neutral$91.2B9.03%-28.63-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$141.7B192.56%32.2786.04%0.00%
Regeneron image
Regeneron
Buy$99.4B52.18%20.7385.77%0.38%

Stock Returns calculator for 60 Degrees Pharmaceuticals, Inc. Stock including INR - Dollar returns

The 60 Degrees Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

60 Degrees Pharmaceuticals, Inc. investment value today

Current value as on today

₹19,615

Returns

-₹80,385

(-80.39%)

Returns from 60 Degrees Pharmaceuticals, Inc. Stock

-₹81,610 (-81.61%)

Dollar Impact

₹1,224 (+1.22%)

Analyst Recommendation on 60 Degrees Pharmaceuticals, Inc. Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for 60 Degrees Pharmaceuticals, Inc.. Average target price of $3.7

60 Degrees Pharmaceuticals, Inc. Share Price Target

Get share price movements and forecasts by analysts on 60 Degrees Pharmaceuticals, Inc..

What analysts predicted

74.15%UPSIDE

Target Price

$3.7

Current Price

$0.9563

Analyzed by

8 Analysts

Target

$3.70

60 Degrees Pharmaceuticals, Inc. target price $3.7, a slight upside of 74.15% compared to current price of $0.9563. According to 8 analysts rating.

Indian Investors' Interest in 60 Degrees Pharmaceuticals, Inc. Stock

Search interest for 60 Degrees Pharmaceuticals, Inc. Stock has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:38% versus previous 30 day period

60 Degrees Pharmaceuticals, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-1
-1
-4
-2
-2
-1
-1
-2
-2
-2
EBITDA
-2
0
-4
-2
-2
-1
-1
-2
-2
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
0
-4
-2
-2
-1
-1
-2
-2
-2
Income Tax Expense
0
0
0
0
0
0
0
0
-
-
Net Income
-1
0
-4
-2
-2
-1
-1
-2
-2
-2
Net Profit Margin
-242.47%
38.08%
28.33%
17.45%
54.84%
55.20%
50.41%
-22.87%
47.12%
27.32%

60 Degrees Pharmaceuticals, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Mar 2026
Total Revenue
2
1
0
0
0
1
Gross Profit
1
0
0
0
0
0
Operating Income
0
-1
-1
-5
-9
-7
EBITDA
0
-1
-2
-1
-7
-7
Interest Expense
2
3
3
2
0
0
Depreciation
0
0
0
0
0
0
Income Before Tax
-3
-4
-6
-3
-7
-7
Income Tax Expense
0
0
0
0
0
-
Net Income
-3
-4
-6
-3
-7
-7
Net Profit Margin
67.77%
26.68%
-93.71%
-87.15%
36.67%
22.26%

60 Degrees Pharmaceuticals, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-2
0
-4
-2
-2
-1
-1
-2
-2
-2
Operating Cash Flow
0
-1
-1
-1
-1
-1
-1
-2
-2
-2
Investing Cash Flow
0
0
0
-1
0
1
0
0
1
0
Financing Cash Flow
-
1
0
5
0
1
-
4
3
-
Change in Cash
0
0
-1
1
-1
1
-1
2
1
-2

60 Degrees Pharmaceuticals, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Mar 2026
Net Income
-3
-4
-6
-3
-7
-7
Operating Cash Flow
0
0
-1
-4
-5
-6
Investing Cash Flow
0
0
0
0
-1
0
Financing Cash Flow
0
0
1
6
7
6
Change in Cash
0
0
0
1
0
0

Global Institutional Holdings in 60 Degrees Pharmaceuticals, Inc.

Check out the Institutions with significant holdings in 60 Degrees Pharmaceuticals, Inc..

Funds
Holdings
GEOFFREY S DOW
0.69%
Fidelity Concord Street Trust
0.41%

60 Degrees Pharmaceuticals, Inc. News & Key Events

  • img

    Today's Timeline - 27 October

    Tue, 06:55 PM

    -

    60 Degrees reports all five patients improved in babesiosis study, with negative PCR tests for Babesia, supporting tafenoquine's efficacy.

Insights on 60 Degrees Pharmaceuticals, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 162.09K → 207.89K (in $), with an average increase of 22.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 996.7% return, outperforming this stock by 1078.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 233.3% return, outperforming this stock by 332.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -1.44M → -2.26M (in $), with an average decrease of 26.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SXTP stock has moved down by -33.6%

About 60 Degrees Pharmaceuticals, Inc.

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical firm dedicated to developing and bringing to market therapies aimed at preventing and treating infectious diseases within the United States. The company currently offers Arakoda, an approved medication for malaria prophylaxis. Its pipeline includes several investigational drugs: Tafenoquine, in its 'Arakoda regimen' formulation, is undergoing Phase IIb clinical trials for potential use against COVID-19. Additionally, Tafenoquine is the subject of Phase IIA clinical studies for conditions such as babesiosis, fungal pneumonias, and candidiasis. Another candidate, Celgosivir, is being developed to address Zika, various respiratory viruses, and dengue fever. Further strengthening its development efforts, 60 Degrees Pharmaceuticals holds a patent license agreement with Tufts Medical Center, collaborating to advance Tafenoquine specifically for the treatment and prevention of babesiosis. The company was established in 2010 and maintains its corporate headquarters in Washington, D.C.
Organisation60 Degrees Pharmaceuticals, Inc.
Headquarters1025 Connecticut Avenue NW, Washington, DC, 20036, US
IndustryBiotechnology
CEOGeoffrey Stuart Dow

Key Management of 60 Degrees Pharmaceuticals, Inc.

Name

Title

Ms. Kristen Landon

Chief Commercial Officer

Dr. Bryan Smith

Chief Medical Officer

Dr. Geoffrey Stuart Dow Ph.D.

Chairman, CEO & President

Mr. Tyrone Miller

Chief Financial Officer

FAQs

What is 60 Degrees Pharmaceuticals, Inc. share price today?

60 Degrees Pharmaceuticals, Inc. share price today is $0.96 as on at the close of the market. 60 Degrees Pharmaceuticals, Inc. share today touched a day high of $0.99 and a low of $0.92.

What is the 52 week high and 52 week low for 60 Degrees Pharmaceuticals, Inc. share?

60 Degrees Pharmaceuticals, Inc. share touched a 52 week high of $8.62 on and a 52 week low of $0.59 on . 60 Degrees Pharmaceuticals, Inc. stock price today i.e. is closed at $0.96,which is 88.91% down from its 52 week high and 62.64% up from its 52 week low.

What is 60 Degrees Pharmaceuticals, Inc.'s market capitalisation today?

60 Degrees Pharmaceuticals, Inc. market capitalisation is $0.00T as on .

How to invest in 60 Degrees Pharmaceuticals, Inc. Stock (SXTP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for 60 Degrees Pharmaceuticals, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy 60 Degrees Pharmaceuticals, Inc. Stock (SXTP) from India?

Indian investors can start investing in 60 Degrees Pharmaceuticals, Inc. (SXTP) shares with as little as ₹94.63999938964844 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.40 in 60 Degrees Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on 60 Degrees Pharmaceuticals, Inc. share’s latest price of $0.96 as on November 5, 2026 at 8:45 am IST, you will get 10.4570 shares of 60 Degrees Pharmaceuticals, Inc.. Learn more about fractional shares .